Kidney damage after renal ablation is worsened in endothelial nitric oxide synthase (-/-) mice and improved by combined administration of L-arginine and antioxidants

Nephrology

Volumn 13, Issue 3, 2008, Pages 218-227

  Mendoza, Monica G Arellano ^a   Castillo Henkel, Carlos ^a   Medina Santillan, Roberto ^a   Jarillo Luna, R Adriana ^a   Robles, Hilda Vargas ^a   Romo, Eunice ^a   Rios, Amelia ^a   Escalante, Bruno ^a  

^a DEPARTAMENTO DE FÍSICA   (Mexico)

Author keywords

Kidney failure; L arginine; Nitric oxide; Reactive oxygen species

Indexed keywords

ALPHA TOCOPHEROL; ARGININE; ASCORBIC ACID; CORABION; DEHYDROASCORBIC ACID; NITRIC OXIDE SYNTHASE; OMEGA 3 FATTY ACID; SUPEROXIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD PRESSURE; CLINICAL EVALUATION; CONTROLLED STUDY; DRUG EFFECT; HISTOPATHOLOGY; KIDNEY FUNCTION; KIDNEY INJURY; MALE; MOUSE; NEPHRECTOMY; NONHUMAN; PRIORITY JOURNAL; PROTEINURIA; URINARY EXCRETION;

EID: 40349089601     PISSN: 13205358     EISSN: 14401797     Source Type: Journal    
DOI: 10.1111/j.1440-1797.2007.00897.x     Document Type: Article

References (34)

1. 1 Modlinger PS, Wilcox CS, Aslam S. Nitric oxide, oxidative stress and progression of chronic renal failure. Semin. Nephrol. 2004 ; 24: 354–65.
2. 2 Vaziri ND, Ni Z, Oveisi F. Enhanced nitric oxide inactivation and protein nitration by reactive oxygen species in renal insufficiency. Hypertension 2002 ; 39: 135–41.
3. 3 Gaertner SA, Janssen U, Ostendorf T. Glomerular oxidative and antioxidative systems in experimental mesangio‐proliferative glomerulonephritis. J. Am. Soc. Nephrol. 2002 ; 13: 2930–37.
4. 4 Hasdan G, Benchetrit S, Rashid G. Endothelial dysfunction and hypertension in 5/6 nephrectomized rats are mediated by vascular superoxide. Kidney Int. 2002 ; 61: 586–90.
5. 5 Paller MS, Hoidal JR, Ferris TF. Oxygen free radicals in ischemic acute renal failure in the rat. J. Clin. Invest. 1984 ; 74: 1156–64.
6. 6 Chatterjee PK, Cuzzocrea S, Brown PA. Tempol a membrane‐permeable radical scavenger, reduces oxidant stress‐mediated renal dysfunction and injury in the rat. Kidney Int. 2000 ; 58: 658–73.
7. 7 Fujii T, Takaoka M, Ohkita M, Matsumura Y. Tempol protects against ischemic acute renal failure by inhibiting renal noradrenaline overflow and endothelin‐1 overproduction. Biol. Pharm. Bull. 2005 ; 28: 641–5.
8. 8 Clermont G, Lecour S, Lahet J. Alteration in plasma antioxidant capacities in chronic renal failure and hemodialysis patients. A possible explanation for the increased cardiovascular risk in these patients. Cardiovasc. Res. 2000 ; 47: 618–23.
9. 9 Ikizler TA, Morrow JD, Roberts LJ. Plasma F2 isoprostane levels are elevated in chronic hemodialysis patients. Clin. Nephrol. 2003 ; 58: 190–97.
10. 10 Mimic‐Oka J, Simic T, Djukanovic L. Alteration in plasma antioxidant capacity in various degrees of chronic renal failure. Clin. Nephrol. 1999 ; 51: 233–41.
11. 11 Noiri E, Peresleni T, Miller F, Goligorsky MS. Antisense oligonucleotides to the inducible NOS prevent tubular cell death in ischemic acute renal failure. J. Clin. Invest. 1996 ; 97: 2377–83.
12. 12 Baylis C. Nitric oxide deficiency in chronic renal disease. Eur. J. Clin. Pharmacol. 2006 ; 62: 123–30.
13. 13 Vallance P, Leone A, Calver A. Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure. Lancet 1992 ; 339: 572–5.
14. 14 Scmidt RJ, Bayliss C. Total nitric oxide production is low in patients with chronic renal disease. Kidney Int. 2000 ; 58: 1261–6.
15. 15 Crow JP, Beckman JS. The importance of superoxide in nitric oxide‐dependent toxicity. In: Snyder R (ed.) Biological Reactive Intermediates. New York: Plenum Press, 1996 ; 147–61.
16. 16 Podjarny E, Hasdan G, Berheim J et al. Effect of chronic tetrahydrobiopterin supplementation on blood pressure and proteinuria in 5/6 nephrectomized rats. Nephrol. Dial. Transplant. 2004 ; 19: 2223–7.
17. 17 Schneider R, Raff U, Vorberger N et al. L‐Arginine counteracts nitric oxide deficiency and improves the recovery phase of ischemic acute renal failure in rats. Kidney Int. 2003 ; 64: 216–25.
18. 18 Rodriguez‐Iturbe B, Ferrebuz A, Vanegas V et al. Early treatment with cGMP phosphodiesterase inhibitor ameliorates progression of renal damage. Kidney Int. 2005 ; 68: 2131–42.
19. 19 Chen SZ, Evans GA. A simple method for transgenic mice using the polymerase chain reaction. Biotechniques 1990 ; 8: 32–3.
20. 20 Sanchez PL, Salgado LM, Ferreri NR, Escalante B. Effects of cyclooxygenase‐2 inhibition on renal function alter renal ablation. Hypertension 1999 ; 34: 848–53.
21. 21 Bradford MM. A rapid and sensitive method for the quantization of microgram quantities of protein utilizing the principle of protein dye binding. Anal. Biochem. 1976 ; 72: 248–54.
22. 22 Hevel JM, Marletta M‐A. Nitric oxide synthase assays. Methods Enzymol. 1994 ; 223: 250–58.
23. 23 Green LC, Wagner DA, Glogowski J, Skipper PL, Wishnok JS, Tannenbaum SR. Analysis of nitrate, nitrite, and [ 15 N] nitrate in biological fluids. Anal. Biochem. 1982 ; 126: 131–8.
24. 24 Miller FJ Jr, Gulterman DD, Rios CD, Heistad DD, Davidson BL. Superoxide production in vascular smooth muscle contributes to oxidative stress and impaired relaxation in atherosclerosis. Circ. Res. 1998 ; 82: 1298–305.
25. 25 Rothe G, Valet G. Flow cytometric analysis of respiratory Bursa activity in phagocytes whit hydroethidine and 2′,7′‐dichlorofluorescein. J. Leukoc. Biol. 1995 ; 55: 253–8.
26. 26 McCord JM. Oxygen‐derived free radicals in post‐ischemic tissue injury. N. Engl. J. Med. 1985 ; 312: 159–63.
27. 27 Noiri E, Nakao A, Uchida K. Oxidative and nitrosative stress in acute renal ischemia. Am. J. Physiol. 2001 ; 281: F948–57.
28. 28 Beckman JS, Koppenol WH. Nitric oxide, superoxide and peroxynitrite: The good, the bad and the ugly. Am. J. Physiol. 1996 ; 271: C1424–37.
29. 29 Chander V, Chopra K. Protective effect of nitric oxide pathway in resveratrol renal ischemia‐reperfusion injury in rats. Arch. Med. Res. 2006 ; 37: 19–26.
30. 30 Doi K, Suzuki Y, Nakao A, Fujita N, Noiri E. Radical scavenger edaravone developed for clinical use ameliorates ischemia/reperfusion injury in rat kidney. Kidney Int. 2004 ; 64: 1714–23.
31. 31 Bramm B, Koomans HA. Nitric oxide antagonizes the actions of angiotensin II to enhance tubuloglomerular feedback responsiveness. Kidney. Int. 1995 ; 48: 1406–11.
32. 32 Welch WJ, Wilcox CS. Macula densa arginine delivery and uptake in the rat regulates glomerular capillary pressure. Effects of salt intake. J. Clin. Invest 1997 ; 100: 2235–42.
33. 33 Das A, Xi L, Kukreja RC. Phosphodiesterase‐5 inhibitor Sildenafil preconditions adult cardiac myoctytes against necrosis and apoptosis. Essential role of Nitric Oxide signaling. J. Biol. Chem. 2005 ; 280: 12944–55.
34. 34 Davis Manning R, Tian N, Meng S. Oxidative stress and antioxidant treatment in hypertension and the associated renal damage. Am. J. Nephrol. 2005 ; 25: 311–17.